EBV+HL and EBV+nHL are generally characterized either by the EBV latency II or III gene expression profile, respectively, which are hallmarked by a high expression of EBV LMP-1 (21). This evidence concerns the gene PDLIM7 and non-Hodgkin lymphoma.